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DETECTING HYPOTHYROIDISM
SiR,&ncedil;The scheme described by Dr. Philp and his colleagues 1
for the detection of hypothyroidism in thyrotoxic patients
treated with radioiodine is admirable and imaginative in per-
mitting identification of these patients at risk. While admitting
that the smaller number of clinical features to be sought does
provide greater simplicity than the diagnostic index for hypo-
thyroidism previously described,2 I am surprised that their
index does not appear to include the muscle complaints of
cramps, 
" heaviness ", or " tightness " so common in these
individuals. In a study some years ago in Sir Edward Wayne’s
department, I found that, whereas only 36% of 100 patients
with primary hypothyroidism had these complaints, " muscle
pain " was present in 71% of 35 individuals with iatrogenic
hypothyroidism. Conversely, parsesthesiae, which are included
in this index, were present in 56% of the primary group but
in only 46% of the iatrogenic group. These were small numbers
but later experience has fully confirmed that muscle pain is
extremely common in patients rendered hypothyroid by
radioiodine therapy and indeed is often the premonitory
complaint. This, of course, is not a new observation, since
Kocher was particularly impressed by this complaint in
patients after thyroidectomy in his classic paper in 1883 on
" cachexia struipriva ".3
I. P. C. MURRAY.
Department of Nuclear Medicine,
Prince of Wales Hospital,
Sydney, Australia.
HAND-FOOT-UTERUS SYNDROME
SIR,-We have recently investigated a family in which 12
living members of 4 generations have mild hypoplasia and
dysplasia of the hands and feet. The hand shows mild
clinodactyly, especially of the fifth digit, with shortening and
malposition of the thumb. The feet are strikingly small. An
undersized forefoot causes the ankle, which is normal, to
appear thick and heavy by contrast. A shortened first meta-
tarsal causes the great toe to come short of the line of the other
toes. In addition, at least 4 affected females in 3 consecutive
generations have duplication anomalies of the mullerian-duct
derivatives, including double uterus, double cervix, and
septate vagina.
The propositus was at first thought to have Holt-Oram
syndrome,4 because he had a ventricular septal defect as well as
malformed thumbs. However, he also had the aforementioned
foot changes, and did not have the shoulder-girdle abnormalities
or atrioventricular-conduction defect usually found in persons
with Holt-Oram syndrome. The other living affected
members did not have congenital heart-disease. Two struc-
turally variant chromosomes (one each in the D and E groups)
were observed in cultured peripheral leucocytes of the pro-
positus ; several other family members, unaffected as well as
affected, had one or the other but not both marker chromo-
somes. We suggest that the " structural load " 5 of two variant
chromosomes, in association with the trait for small hands and
feet, may have been sufficient to exceed a critical threshold,
resulting in congenital heart-disease in the propositus.
Dermatoglyphic studies showed striking departures from the
usual. Of 8 tested affected family members, all had a distally
placed axial triradius, and 7 had low arches on both thumbs.
No whorls were present on any finger. Loops were exclusively
ulnar-directed and very thin, averaging only 3 or 4 ridges from
triradius to core. Total fingerprint-ridge count was drastically
reduced from normal, averaging about 24 ridges for all 10
fingers. Unaffected family members had normal fingerprint
and palm patterns.
This syndrome has in common with Holt-Oram syndrome
malformation of the hand, with the thumb showing most
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pronounced involvement. However, the bony involvement in
Holt-Oram syndrome includes the entire upper appendicular
skeleton, often with severe degrees of malformation, while the
hand anomaly in this family was mild and easily missed if not
looked for, and with no involvement beyond the wrist. Finger-
prints in Holt-Oram syndrome are fairly normal In addition,
the feet are never involved in the Holt-Oram syndrome.
Duplication anomalies of the uterus have not been reported
in Holt-Oram syndrome, nor indeed, so far as we have been
able to discover, in any other regularly inherited entity.6 7
In view of the fairly mild clinical manifestations of this
syndrome, it should not be excessively rare.
A complete report is being prepared for publication. Partial
support for the study of this family has been provided by National
Institutes of Health research grant HD 02083.
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SIR,-Dr. Pantridge a reiterates, in reply to Dr. Pentecost
and his colleagues,9 that the bradycardia in patients with
myocardial infarction is an important feature related to serious
complications (e.g., fatal arrhythmia), and that the bradycardia
" sensitises " the heart to ventricular fibrillation. The brady-
cardia early in infarction may be due to release of adenosine-
type compounds,lO and this in itself may seriously impair an
already weakened myocardium. Adenosine produces brady-
cardia, which may be severe (thereby impairing coronary flow),
and even asystole, and its action is not reversed by atropine.
There may be immediate death from asystole or ventricular
fibrillation, later death from hormonal release (adenosine with
asystole, adrenaline with ventricular fibrillation), or delayed
death from gradual failure.
E. R. TRETHEWIE.
Mount Sinai Hospital,
New York, N.Y. 10029.
CHLORPROPAMIDE IN DIABETES INSIPIDUS
SIR,-The antidiuretic action of chlorpropamide in diabetes
insipidus was described by Arduino et al. in 1966.11 The useful-
ness of this agent has since been confirmed by Meinders et al.12
and Reforzo-Membrives et a1.13 Reforzo-Membrives et al.13
have also shown that the primary effect of chlorpropamide,
both in normal subjects and in patients with diabetes insipidus,
is a decrease in the renal free-water clearance. This effect is
specific for chlorpropamide, for none of the other commonly
used sulphonylureas were found to be active. We describe
here our experience with the drug at this hospital in the past
year.
A 5-year-old girl, known to have histiocytosis X since the
age of 2 years (diagnosed by biopsy of a swelling in relation
to right parietal bone), had developed diabetes insipidus at the
age of 3 years, and had required Pitressin’ (vasopressin
injection) for its control. She was taken off pitressin on Sept. 1,
1968; on Oct. 1 her urine volume was 6360 ml. Her urine
specific gravity stayed at 1001. She was started on chlor-
propamide 100 mg. daily. No change in urine volume or
specific gravity occurred. The dose was increased to 150 mg.
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